Gulf Pharmaceutical Industries
Year to date
0.35 %
3 months
0.00 %
6 months
0.00 %
1 year
0.00 %
3 years
0.00 %
5 years
0.00 %
Latest Pressrelease Summaries
Threads
The Abu Dhabi Securities Exchange has issued a resolution to suspend the trading of Gulf Pharmaceutical Industries shares starting from October 23, 2024, until further notice. This decision is in accordance with Articles 10/11 and 38 of the ADX Listing and Disclosure Rules. All relevant departments and brokers are required to implement this resolution, which will be effective from the issuance date. The resolution was issued by Abdulla Salem ALNuaimi, the Chief Executive Officer of ADX.
Gulf Pharmaceutical Industries P.S.C. has released its unaudited interim condensed consolidated financial statements for the period ending 30 June 2024.
Resolution No. 465 of 2024 announces the temporary suspension of trading for Gulf Pharmaceutical Industries (JULPHAR) shares on the Abu Dhabi Securities Exchange (ADX). This suspension will start at 12:00 PM on August 14, 2024, due to a Board of Directors meeting that coincides with the trading session. Trading will resume once ADX receives the meeting results. The resolution requires all ADX department heads to implement this decision and mandates its circulation to the Securities and Commodities Authority (SCA), the concerned company, relevant ADX departments, and accredited brokers. The resolution was approved by the authorized person and issued on August 8, 2024.